Cargando…
Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy
Nemaline myopathy (NEM) is a congenital neuromuscular disorder primarily caused by nebulin gene (NEB) mutations. NEM is characterized by muscle weakness for which currently no treatments exist. In NEM patients a predominance of type I fibers has been found. Thus, therapeutic options targeting type I...
Autores principales: | Lindqvist, Johan, Lee, Eun-Jeong, Karimi, Esmat, Kolb, Justin, Granzier, Henk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853306/ https://www.ncbi.nlm.nih.gov/pubmed/31721788 http://dx.doi.org/10.1371/journal.pone.0224467 |
Ejemplares similares
-
Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism
por: Lindqvist, Johan, et al.
Publicado: (2020) -
Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene
por: de Winter, Josine M, et al.
Publicado: (2015) -
Functional Characterization of the Intact Diaphragm in a Nebulin-Based Nemaline Myopathy (NM) Model-Effects of the Fast Skeletal Muscle Troponin Activator tirasemtiv
por: Lee, Eun-Jeong, et al.
Publicado: (2019) -
Failure to identify modifiers of NEBULIN-related nemaline myopathy in two pre-clinical models of the disease
por: Qiu, Boyang, et al.
Publicado: (2019) -
Clinical Manifestation of Nebulin-Associated Nemaline Myopathy
por: Moreno, Cristiane Araujo Martins, et al.
Publicado: (2023)